Lange, Lars
Klimek, Ludger
Beyer, Kirsten
Blümchen, Katharina
Novak, Natalija
Hamelmann, Eckard
Bauer, Andrea
Merk, Hans
Rabe, Uta
Jung, Kirsten
Schlenter, Wolfgang
Ring, Johannes
Chaker, Adam
Wehrmann, Wolfgang
Becker, Sven
Mülleneisen, Norbert
Nemat, Katja
Czech, Wolfgang
Wrede, Holger
Brehler, Randolf
Fuchs, Thomas
Jakob, Thilo
Ankermann, Tobias
Schmidt, Sebastian M.
Gerstlauer, Michael
Zuberbier, Torsten
Spindler, Thomas
Vogelberg, Christian
Funding for this research was provided by:
Universitätsklinikum Carl Gustav Carus Dresden an der Technischen Universität Dresden
Article History
Received: 19 April 2021
Accepted: 21 June 2021
First Online: 28 September 2021
Conflict of interest
: L. Lange reports fees for consulting from Aimmune, DBV Technologies, and Nestlé. L. Lange reports fees for lectures from Aimmune, DBV Technologies, Nestlé und Nutricia. L. Klimek reports grants and/or personal fees from Allergopharma, MEDA/Mylan, HAL Allergie, ALK Abelló, LETI Pharma, Stallergenes, Quintiles, Sanofi, ASIT biotech, Lofarma, Allergy Therapeut., AstraZeneca, GSK, Inmunotek, Cassella med, and Novartis, outside the submitted work; and Membership: AeDA, DGHNO, Deutsche Akademie für Allergologie und klinische Immunologie, HNO-BV, GPA, EAACI. L. Klimek is the editor in chief of the Allergo Journal and Allergo Journal International in which this manuscript will be published. K. Beyer reports grants and/or personal fees from Danone/Nutricia/Milupa, DBV, Hipp, Hycor, Infectopharm, Jenapharma, Mylan/Meda, Nestle, Novartis, ThermoFisher, Aimmune, Bencard, and ALK, outside the submitted work. N. Novak reports grants and/or personal fees from Alk Abello, HAL Allergy, Stallergenes Geer, Leti Pharma, Sanofi Genzyme, Novartis, Leo Pharma, Abbvie, and Blueprint, outside the submitted work. H. Merk reports personal fees and/or grants from Meda, Stallergenes, Sanofi, Bayer, BMS, and J&J, during the conduct of the study. T. Jakob reports grants, personal fees and/or non-financial support from Novartis, ALK-Abello, Allergy Therapeutics/Bencard, Allergopharma, and Thermo Fisher, outside the submitted work. T. Jakob is the coeditor in chief of the Allergo Journal and Allergo Journal International in which this manuscript will be published. T. Ankermann reports personal fees from Aimmune, during the conduct of the study. K. Blümchen, E. Hamelmann, A. Bauer, U. Rabe, K. Jung, W. Schlenter, J. Ring, A. Chaker, W. Wehrmann, S. Becker, N. Mülleneisen, K. Nemat, W. Czech, H. Wrede, R. Brehler, T. Fuchs, S.M. Schmidt, M. Gerstlauer, T. Zuberbier, T. Spindler and C. Vogelberg declare that they have no competing interests.